Trial intelligence / Profile preview

Naproxen Sodium vs Ibuprofen in Postsurgical Dental Pain

NCT03404206Phase 4Completed

Sponsor
Bayer
Start
Feb 2018
Primary completion
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Aprol in postoperative pain (3 arms), sponsored by Bayer. Primary endpoint: Time to First Use of Rescue Medication at 24 hours. Started Feb 2018; status: completed.

02

Drugs

Aprol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03404206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03404206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call